Cite
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
MLA
Marinella Zilli, et al. “Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies.” Cancers, vol. 5, no. 3, July 2013, pp. 919–42. EBSCOhost, https://doi.org/10.3390/cancers5030919.
APA
Marinella Zilli, Laura Iezzi, Felice Simiele, Antonino Grassadonia, Pasquale Cioffi, & Clara Natoli. (2013). Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers, 5(3), 919–942. https://doi.org/10.3390/cancers5030919
Chicago
Marinella Zilli, Laura Iezzi, Felice Simiele, Antonino Grassadonia, Pasquale Cioffi, and Clara Natoli. 2013. “Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies.” Cancers 5 (3): 919–42. doi:10.3390/cancers5030919.